Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.
about
PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic DrugsDiabetes, use of antidiabetic drugs, and the risk of gliomaLow concentrations of metformin selectively inhibit CD133⁺ cell proliferation in pancreatic cancer and have anticancer actionRepurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastomaCancer stem cells: a systems biology view of their role in prognosis and therapySynthesis and anti-breast cancer evaluation of novel N-(guanidinyl)benzenesulfonamidesOpioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastomaMetformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes.microRNAs and cancer metabolism reprogramming: the paradigm of metforminBerberine suppresses gero-conversion from cell cycle arrest to senescence.Effects of metformin on retinoblastoma growth in vitro and in vivo.Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells.Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma.Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion currentEffects of metformin on CD133+ colorectal cancer cells in diabetic patientsIn vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumorsMetformin inhibits growth of human glioblastoma cells and enhances therapeutic responseFasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models.Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment StrategiesMetformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling.Paeoniflorin inhibits human glioma cells via STAT3 degradation by the ubiquitin-proteasome pathway.Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells.Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cellsTemozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells.Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCsMetformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2.Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLC.Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells.Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cellsDirect inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer.Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention.Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.Dynamic Interactions Between Cancer Stem Cells And Their Stromal Partners.Obesity and melanoma: exploring molecular links.Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells.Glioma stem cells: markers, hallmarks and therapeutic targeting by metformin.
P2860
Q28066756-9B329479-7F33-4F80-BFE9-CE8CB6F1E85BQ28387952-D3110918-C541-4C2C-ACA6-0B709053AC12Q28487772-921CE3B9-E206-4A1F-8741-1E91CCE94B43Q28816972-833003BA-D029-4048-BA18-D80589DAA9E9Q33569712-9F5ADC5B-2E11-434C-9BE8-E6B4F53D0A37Q33580445-4F83697A-2595-460A-8937-36435BF98D6EQ33728939-6BDD1C81-6C1F-481A-99C7-BB7DE50082B3Q34323510-BFA8B944-344A-42DA-86B9-D893457DE1F5Q34357915-679E7372-7597-4A09-B0A8-077D47851B3BQ34366519-17FF48C7-DB11-472F-9F53-8D4847ACA414Q34432841-F60A2FB6-E1DF-4828-B838-2FAD7EE97B74Q34483548-A7A52E16-A1C8-4C49-BF72-EA3FD8CF37C5Q34957038-2A7F2D29-0AE9-44A4-9058-23C9221437D9Q34957274-DA3FEFE6-2954-4A10-90A8-E2671F97C295Q35053962-B0F46AA1-B05D-4A1E-9574-F7DC158EB2ADQ35425337-136CD1CB-DFF6-4984-B2FB-5BFA1DE23151Q35600122-3E9FAD83-D27F-4CD2-B9AB-63CD139127E3Q35828442-27F0F565-47FA-4A7B-8C7C-8CD4D398F755Q35982489-0F59D3FF-CE47-44AB-9C76-6D33D1874549Q36099266-E2AA3E86-20DF-468B-BE28-14E0055D9577Q36176779-83E00716-9E5A-43FD-8DFD-D3A177D04C09Q36305220-437A67BD-81AA-40D2-A43D-849ED783F7DFQ36545028-D8D08886-EEAB-47B7-822E-29D10439C5AFQ36561571-EED912F1-49A7-4AAA-B285-50815618CC80Q36654402-E29A4A33-35B4-4156-BEA4-38FFB7B27081Q36678490-67A845E2-CC43-47DF-9F52-9039AF04BE40Q36741098-835C99FF-89AB-468F-9B1B-1508B2B8728EQ37091938-69358A49-3985-4EDB-B968-FBF89645B587Q37118676-B146AA8D-43D4-4745-B197-093888C55DFFQ37151297-B65ABA2D-56CE-4E23-997D-8BD54CD51F47Q37368670-77BC19EE-0A91-4C73-BEF9-9912A0971116Q37437614-52CC942B-DA1F-4719-BF9F-E4734EE99F1EQ37530258-133E24AE-331C-4BBB-A1C4-EC50B52ADCB5Q37608817-808B8C56-D7B7-41DD-8F21-A3D19ADD81AFQ37610799-8286A62B-F142-4585-8456-ECBA318134A9Q37641700-48F637D5-121D-42B5-AD14-8036F6962C3FQ38095892-3E724140-522D-46AF-8CF4-FEFEDFDF2A69Q38185970-3C55F1F8-5F97-4DD7-A513-33329FF7955FQ38187997-1BC15E34-C7D1-4493-962B-5ECA167A3C29Q38244345-956D8FDC-730C-492D-B0F9-0B7F71E3AC47
P2860
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Metformin selectively affects ...... min-induced inhibition of Akt.
@ast
Metformin selectively affects ...... min-induced inhibition of Akt.
@en
type
label
Metformin selectively affects ...... min-induced inhibition of Akt.
@ast
Metformin selectively affects ...... min-induced inhibition of Akt.
@en
prefLabel
Metformin selectively affects ...... min-induced inhibition of Akt.
@ast
Metformin selectively affects ...... min-induced inhibition of Akt.
@en
P2093
P2860
P50
P356
P1433
P1476
Metformin selectively affects ...... rmin-induced inhibition of Akt
@en
P2093
Adirano Bajetto
Alessandra Pattarozzi
Alessia Parodi
Gianluigi Zona
Monica Gatti
Rodolfo Sirito
P2860
P304
P356
10.4161/CC.23050
P50
P577
2012-12-19T00:00:00Z